A novel office-based injectable to treat duchenne-related fibrosis

Ended Project Grant Awarded Last action

Award ID
W81XWH2110719
Recipient
Awarding agency
Obligated
$675,447

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Originally
Place of performance
Lexington, MA 02421, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment This modif ication: 1. Extends the POP by 12 months. All other technical and financial reporting shall continue in accordance W ITH the AW ARD terms and… $0
Amendment A novel office-based injectable to treat duchenne-related fibrosis extend the period of performance 1. Per section 711 of the national defense authorization act… $0
Original award $675,447

Quick answers

Who received award W81XWH2110719?

W81XWH2110719 was awarded to Ortholevo, Inc. by Defense Health Agency (Department of Defense) on September 1, 2021.

How much is award W81XWH2110719 worth?

$675,447 has been obligated on W81XWH2110719.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login